Bausch Health Cos Pre-Tax Profit Margin 2010-2024 | BHC

Bausch Health Cos pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Bausch Health Cos Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-09-30 $9.47B $-0.05B -0.52%
2024-06-30 $9.20B $-0.35B -3.85%
2024-03-31 $8.97B $-0.32B -3.60%
2023-12-31 $8.76B $-0.39B -4.45%
2023-09-30 $8.54B $-0.74B -8.66%
2023-06-30 $8.35B $0.03B 0.30%
2023-03-31 $8.15B $-0.18B -2.25%
2022-12-31 $8.12B $-0.13B -1.59%
2022-09-30 $8.13B $0.25B 3.06%
2022-06-30 $8.19B $0.03B 0.32%
2022-03-31 $8.33B $-0.52B -6.19%
2021-12-31 $8.43B $-1.02B -12.14%
2021-09-30 $8.45B $-1.44B -17.03%
2021-06-30 $8.48B $-1.58B -18.64%
2021-03-31 $8.04B $-1.35B -16.75%
2020-12-31 $8.03B $-0.93B -11.64%
2020-09-30 $8.04B $-2.01B -25.01%
2020-06-30 $8.11B $-2.15B -26.53%
2020-03-31 $8.60B $-1.89B -22.02%
2019-12-31 $8.60B $-1.84B -21.36%
2019-09-30 $8.50B $-0.79B -9.33%
2019-06-30 $8.43B $-1.03B -12.19%
2019-03-31 $8.40B $-1.58B -18.83%
2018-12-31 $8.38B $-4.15B -49.57%
2018-09-30 $8.42B $-4.53B -53.81%
2018-06-30 $8.51B $-4.63B -54.46%
2018-03-31 $8.61B $-4.14B -48.08%
2017-12-31 $8.72B $-1.74B -19.96%
2017-09-30 $8.96B $-1.30B -14.47%
2017-06-30 $9.22B $-2.23B -24.17%
2017-03-31 $9.41B $-2.36B -25.12%
2016-12-31 $9.67B $-2.44B -25.17%
2016-09-30 $10.03B $-2.34B -23.36%
2016-06-30 $10.34B $-1.02B -9.84%
2016-03-31 $10.65B $-0.71B -6.62%
2015-12-31 $10.45B $-0.16B -1.49%
2015-09-30 $9.91B $0.66B 6.70%
2015-06-30 $9.18B $1.05B 11.40%
2015-03-31 $8.49B $1.23B 14.52%
2014-12-31 $8.21B $1.06B 12.86%
2014-09-30 $8.05B $0.43B 5.28%
2014-06-30 $7.53B $-1.09B -14.51%
2014-03-31 $6.59B $-1.25B -19.03%
2013-12-31 $5.77B $-1.31B -22.77%
2013-09-30 $4.63B $-1.51B -32.66%
2013-06-30 $3.97B $-0.46B -11.57%
2013-03-31 $3.69B $-0.44B -11.81%
2012-12-31 $3.48B $-0.39B -11.32%
2012-09-30 $3.21B $-0.20B -6.10%
2012-06-30 $2.93B $-0.10B -3.24%
2012-03-31 $2.72B $-0.03B -1.25%
2011-12-31 $2.43B $-0.02B -0.74%
2011-09-30 $2.29B $-0.08B -3.28%
2011-06-30 $1.90B $-0.24B -12.39%
2011-03-31 $1.53B $-0.24B -15.72%
2010-12-31 $1.18B $-0.24B -20.05%
2010-09-30 $0.91B $-0.06B -6.06%
2010-06-30 $0.91B $0.14B 15.44%
2010-03-31 $0.87B $0.13B 14.98%
2009-12-31 $0.82B $0.18B 21.32%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00